\
&
Contact us
\
&
Contact us
This was 4 years ago
LocationVirtual Event
ProgrammesThe virtual event will showcase policies and practices from across Europe that accelerate the translation of scientific knowledge into products and solutions for the benefit of society.
This new initiative, co-organised by the European Commission and EU Member States, will serve as a forum for peer learning among policy makers and stakeholders. It will foster a dialogue on opportunities and policy responses to ensure that our research and innovation investments pay off in helping to shape the twin green and digital transition and deliver jobs and prosperity in Europe.
More specific information, the agenda and the possibility to register can be found here
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Digital, Industry & Space AI Continent Deployment: Best use of technologies
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
